4 Kukadzi 2022: MuIndia, gomarara rinogona kuve nemhedzisiro yakakomba yemagariro uye hupfumi, izvo zvinokonzeresa hurombo hwemhuri uye kusarongeka kwevanhu. Munyika ino ine vanhu vadiki, huwandu hwechirwere chegomarara hwakagadziridzwa huchiri hwakaderera. Muhuwandu hwevanhu 1.3 bhiriyoni, zvishoma kudarika miriyoni imwe zviitiko zvegomarara zvinoonekwa gore rega rega. Mumashoko akagadziriswa zera, izvi zvinoratidza chikamu chimwe muzvina chezviitiko zvevarume nevakadzi zvinoonekwa muWestern Europe. Gomarara, kune rimwe divi, rakakonzera kufa kunofungidzirwa kuti zviuru mazana matanhatu-1 muIndia muna 600000.
Zvinoenderana neiyo IHME yekudzidza yeGlobal Burden of Disease Study 2019 ongororo, iwo mufananidzo hauna kunyanya kusiyana pasi rose. Muna 2019, huwandu hwekenza itsva dzegomarara dzakapfuura mamirioni makumi maviri nematatu, kubva pamamirioni gumi nemasere. .
Munyika dziri kusimukira nedziri kusimukira, gomarara ndiro riri kukonzera kurwara nekufa. Ruzhinji rwevanhu munyika dzakawanda dzine mari yakaderera uye yepakati, kusanganisira India, havakwanisi kuwana chirongwa chegomarara chakarongeka uye chakanyatsogadziriswa. Kana munhu akabatwa gomarara, kazhinji anomanikidzwa kushandisa mari yakawanda pautano hwake. Mari dzakadaro dzinogona kusundira mhuri dzose muurombo uye, kana dzabatanidzwa nokushaikwa kweanonzi mabasa anogamuchirika, dzinogona kukanganisa kugadzikana kwenzanga. Zvinogona kutaurwa zviri nyore kuti kurapwa kwegomarara muIndia kuchiri mudanho rekutanga uye kukura kukuru kunodiwa mundima iyi.
Kune matambudziko maviri makuru anotarisana nevarwere vegomarara uye nhengo dzemhuri yavo kana munhu akaonekwa aine cancer. Imwe ndeyokuti, vachawana kupi kurapwa kwakanakisisa uye kwakakodzera, uye yechipiri, imarii ichadiwa pakurapwa? Wechipiri ndiwo mubvunzo unonyanya kukosha, sezvo ruzhinji rwevanhu muIndia vachiri vasina inishuwarenzi yehutano. Isu kuCancerFax tinogadzirisa matambudziko ese aya. Isu tinobatsira varwere vegomarara kuwana kwakakodzera uye kwehupfumi kurapwa kwegomarara muIndia nekune dzimwe nyika. CancerFax iri kushanda nevanopfuura zana vezvipatara zvepamusoro zvegomarara munyika gumi dzakaita seDana-Farber, Mayo Clinic, Boston Children's Hospital, Sheba, Asan, Apollo, BLK, Artemis kutaura vashoma.
CAR T-Cell therapy is a breakthrough treatment for some kinds of lymphoma, leukemia and multiple myeloma. CancerFax helps patients enroll for CAR T-Cell kurapa treatment in the USA, Israel and China. Many patients who had previously relapsed blood tumors had no evidence of cancer after CAR T-Cell therapy. It has also aided in the rehabilitation of patients who have previously failed to respond to most traditional cancer therapies. There are more than 300 ongoing clinical trials in the world’s leading cancer centers on this therapy. CAR T-Cell therapy in India is available as clinical trials now. I hope it will be available for commercial treatment very soon.
